{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "North Chicago",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "BLA020725"
        ],
        "brand_name": [
          "CREON"
        ],
        "generic_name": [
          "PANCRELIPASE"
        ],
        "manufacturer_name": [
          "AbbVie Inc."
        ],
        "product_ndc": [
          "0032-0045",
          "0032-1203",
          "0032-1206",
          "0032-1212",
          "0032-1224",
          "0032-3016",
          "0032-0046",
          "0032-0047",
          "0032-2636",
          "0032-2637"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "PANCRELIPASE AMYLASE",
          "PANCRELIPASE LIPASE",
          "PANCRELIPASE PROTEASE"
        ],
        "rxcui": [
          "855495",
          "855499",
          "855503",
          "863829",
          "863836",
          "863841",
          "1113042",
          "1113046",
          "1373325",
          "1373327"
        ],
        "spl_id": [
          "94463229-9296-4640-854f-41d76386d312"
        ],
        "spl_set_id": [
          "073201aa-556d-4a70-918e-84e9616fd88d"
        ],
        "package_ndc": [
          "0032-1203-70",
          "0032-1203-64",
          "0032-1206-07",
          "0032-1206-01",
          "0032-1206-56",
          "0032-1212-07",
          "0032-1212-01",
          "0032-1212-46",
          "0032-1212-13",
          "0032-1224-07",
          "0032-1224-01",
          "0032-1224-46",
          "0032-3016-28",
          "0032-3016-13",
          "0032-3016-50",
          "0032-3016-12",
          "0032-0045-70",
          "0032-0045-30",
          "0032-0046-30",
          "0032-0046-70",
          "0032-0047-30",
          "0032-0047-70",
          "0032-2636-70",
          "0032-2636-01",
          "0032-2636-30",
          "0032-2637-70",
          "0032-2637-01",
          "0032-2637-30"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300322637701",
          "0300320045706",
          "0300320047700",
          "0300320046703",
          "0300323016130",
          "0300322636704",
          "0300321224018"
        ],
        "unii": [
          "8MYC33932O",
          "3560D81V50",
          "YOJ58O116E"
        ]
      },
      "product_type": "Drugs",
      "event_id": "69285",
      "recalling_firm": "AbbVie Inc",
      "address_1": "1 N Waukegan Rd",
      "address_2": "N/A",
      "postal_code": "60064",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US: Nationwide",
      "recall_number": "D-1611-2014",
      "product_description": "CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.",
      "product_quantity": "18,021 Bottles",
      "reason_for_recall": "Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.",
      "recall_initiation_date": "20140915",
      "center_classification_date": "20140926",
      "termination_date": "20160622",
      "report_date": "20141008",
      "code_info": "Lot #: 1020156; Expiry: 3/31/2016"
    }
  ]
}